CD8A and infectious mononucleosis: For instance, in children with infectious mononucleosis, treatment with pidotimod resulted in decreased numbers of CD3+ and CD8+ cells, alongside increased levels of CD4+ cells and elevated CD4+/CD8+ ratios [18].